Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen, Nancy G. Klimas, Z. Fox, A. Phillips, C. Cohen, J. Neuhaus, J. Baxter, S. Emery, B. Hirschel, K. H. Hullsiek, C. Stephan, J. Lundgren, INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group
Faculty Articles

Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up, Nancy G. Klimas, J. D. Lundgren, A. Babiker, W. El-Sadr, S. Emery, B. Grund, J. D. Neaton, J. Neuhaus, A. Phillips
Faculty Articles

Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial, Nancy G. Klimas, W. M. El-Sadr, B. Grund, J. Neuhaus, A. Babiker, C. J. Cohen, J. Darbyshire, S. Emery, J. D. Lundgren, A. Phillips, J. D. Neaton
Faculty Articles